The new ACC and AHA criteria for cardiac devices emphasize more risk stratification, reflecting advances in the field in recent years.

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...

The trial investigated the safety, tolerability, pharmacokinetics, and proof-of-concept after once-weekly subcutaneous administrations of amycretin in 125 people with overweight or obesity.